spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online April 1, 2009
doi: 10.1242/10.1242/jcs.041640


Journal of Cell Science 122, 1220-1228 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, T.
Right arrow Articles by Tojyo, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, T.
Right arrow Articles by Tojyo, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Stim1-dependent, noncapacitative Ca2+-entry pathway is activated by B-cell-receptor stimulation and depletion of Ca2+

Takao Morita1, Akihiko Tanimura1,*, Yoshihiro Baba2, Tomohiro Kurosaki2 and Yosuke Tojyo1

1 Department of Pharmacology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, Japan
2 Laboratory for Lymphocyte Differentiation, RIKEN Research Center for Allergy and Immunology, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan


Figure 1
View larger version (25K):
[in this window]
[in a new window]

 
Fig. 1. BCR-mediated La3+-resistant Ca2+ entry into DT40 cells. (A) WT DT40 cells were stimulated with 3 µg/ml anti-IgM in a nominally Ca2+-free medium, followed by the addition of 1.3 mM Ca2+ in the absence (black) or presence (red) of 0.3 µM La3+. Typical Ca2+ responses in single DT40 cells in the absence (black) and presence (red) of La3+ are shown. Fluorescence ratios (340 nm/380 nm) were normalized to the ratio obtained just before addition of Ca2+ (relative ratios). Horizontal bars indicate the presence of anti-IgM and Ca2+. Time points for the addition of reagents by exchanging medium are indicated by the arrows. The red arrow indicates the time of La3+ addition. (B) Normalized fluorescence ratios were collected at 5 second intervals from cells examined in the absence (black) or presence (red) of La3+. The gray trace indicates the normalized fluorescence ratio in the absence of La3+ and anti-IgM stimulation. Traces shown are the means ± s.e.m. of 187 and 204 cells in the absence or presence of La3+, respectively, and 237 unstimulated cells. Horizontal bars indicate the presence of anti-IgM and Ca2+. (C) WT cells were treated with 1 µM ThG in nominally Ca2+-free medium, followed by the addition of Ca2+ in the absence (black) or presence (red) of La3+. Traces are shown as the means ± s.e.m. of 125 and 191 cells in the absence or presence of La3+, respectively. Horizontal bars indicate the presence of ThG and Ca2+. (D) Anti-IgM (2 µg/ml) was added before the addition of Ca2+ in the presence La3+. The trace shown is the mean ± s.e.m. of 234 cells. Horizontal bars indicate the presence of ThG, anti-IgM, La3+ and Ca2+. (E,F) Effects of La3+ on BCR- or ThG-induced Ca2+ entry into WT (E) and IP3R-KO (F) DT40 cells. Maximal increases in fluorescence ratios following the addition of Ca2+ to cells treated with 0-5 µg/ml anti-IgM or 1 µM ThG in the absence (black columns) or presence (red columns) of La3+. Anti-IgM, ThG, La3+, and Ca2+ were applied at time points depicted in B or C. The total number of cells examined is shown above each column.

 

Figure 2
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 2. BCR-mediated La3+-resistant Ca2+ entry after store depletion in WT and IP3R-KO DT40 cells. (A,B) WT (A) and IP3R-KO (B) DT40 cells were pretreated for 10 minutes with 1 µM ThG in nominally Ca2+-free medium, after which time La3+, Ca2+, and either 2 µg/ml anti-IgM (blue) or vehicle (gray) were added. Traces shown are the means ± s.e.m. of 191 and 202 cells in the absence or presence of anti-IgM in WT cells, and 173 and 198 cells in the absence or presence of anti-IgM in IP3R-KO cells, respectively. The horizontal bars in A and B indicate the presence of ThG, La3+ and Ca2+. Time points for the addition of reagents by exchanging medium are indicated by arrows. Anti-IgM was added at the time indicated by the blue arrow. (C) La3+-resistant Ca2+ entry in the presence of increasing anti-IgM stimulation of ThG-pretreated WT (black) and IP3R-KO (white) cells. Increases in fluorescence ratios at 10 minutes after the addition of various concentrations of anti-IgM (0 µg/ml to 5 µg/ml) to ThG-pretreated cells in the presence of La3+ and Ca2+. Data shown are means ± s.e.m. The total number of cells examined is shown above each column. **P<0.01.

 

Figure 3
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 3. Effects of genistein, U-73122, and staurosporine on BCR-mediated Ca2+ entry following ThG pretreatment. (A-D) WT DT40 cells were treated with ThG in nominally Ca2+-free medium. Subsequently, cells were treated with 50 µM genistein (A), 100 nM staurosporine (B), 2 µM U-73122 (C) or 2 µM U-73343 (D) followed by addition of La3+ and Ca2+ and stimulation with anti-IgM (blue) or vehicle (gray). Traces shown are the means ± s.e.m. of 221 and 201 cells in the absence or presence of anti-IgM in A; 177 and 185 cells in the absence or presence of anti-IgM in B; 180 and 166 cells in the absence or presence of anti-IgM in C; and 188 and 218 cells in the absence or presence of anti-IgM in D, respectively. The horizontal bars indicate the presence of inhibitors, ThG, La3+ and Ca2+. Time points for the addition of reagents by exchanging medium are indicated by the arrows. Anti-IgM was added at the time indicated by the blue arrow. (E) Effects of various inhibitors on BCR-mediated La3+-resistant Ca2+ entry in ThG-pretreated WT and IP3R-KO DT40 cells. Increases in fluorescence ratios of the ThG-pretreated cells were obtained 10 minutes after the addition of 2 µg/ml anti-IgM (black) or vehicle (white) in the presence of La3+, Ca2+, and each inhibitor. The total number of cells examined is shown above each column. **P<0.01.

 

Figure 4
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 4. BCR-mediated Ca2+ entry in Stim1-KO cells. Stim1-KO cells were transfected with the YFP-Stim1 expression vector and Ca2+ responses in YFP-positive (black) and YFP-negative (red) cells were examined. (A) Cells were stimulated with 2 µg/ml anti-IgM in nominally Ca2+-free medium, followed by the addition of La3+ and Ca2+. (B,C) Cells were treated with ThG in nominally Ca2+-free medium, followed by the addition of La3+, Ca2+ and 2 µg/ml anti-IgM (B) or Ca2+ (C). Traces shown are the means ± s.e.m. of normalized fluorescence ratios from Stim1-KO (YFP-negative; red) and YFP-Stim1 overexpressing Stim1-KO (YFP-positive; black) DT40 cells (17 and 217 YFP-positive and -negative cells, respectively, in A; 17 and 229 YFP-positive and -negative cells, respectively, in B; and 7 and 227 YFP-positive and -negative cells, respectively, in C). Horizontal bars indicate the presence of ThG, anti-IgM, La3+ and Ca2+. Time points for the addition of reagents are indicated by the arrows.

 

Figure 5
View larger version (21K):
[in this window]
[in a new window]

 
Fig. 5. Effect of Orai1 siRNA (siOrai1) and Orai2 siRNA (siOrai2) on CCE and BCR-mediated Ca2+ entry following treatment with ThG. (A) WT DT40 cells were cotransfected with the EYFP expression vector and siOrai1 and/or siOrai2. Cells were treated with ThG in nominally Ca2+-free medium and then Ca2+ was added. Traces shown are the means ± s.e.m. of normalized fluorescence ratios from YFP-positive siOrai1-transfected cells (gray), YFP-positive siOrai1- and siOrai2-transfected cells (red), YFP-transfected cells (blue) or untransfected cells (black). The horizontal bars indicate the presence of ThG and Ca2+. Arrows indicate the times of addition of reagents by exchanging medium. Results were obtained from 4-12 independent experiments, and the total number of cells examined is shown above each column in D. (B) WT DT40 cells were cotransfected with the EYFP expression vector and siOrai1 and/or siOrai2. Cells were treated with ThG in nominally Ca2+-free medium and then 3 µg/ml anti-IgM was added in the presence of La3+ and Ca2+. Traces shown are the means ± s.e.m. of normalized fluorescence ratios from YFP-positive siOrai1- and siOrai2-transfected cells (red), YFP-transfected cells (blue) or untransfected cells (black). The horizontal bars indicate the presence of anti-IgM, ThG, La3+ and Ca2+. Results were obtained from 8-10 independent experiments, and the total number of cells examined is shown above each column in panel D. (C) Responses in YFP-positive siOrai1- and siOrai2-transfected cells (red) or YFP-transfected cells (blue) using an expanded scale for the boxed region in B. (D) Effect of siOrai1 and/or siOrai2 on CCE or B-SOC in WT DT40 cells. Increased fluorescence ratios were induced by the addition of Ca2+ to ThG-pretreated WT DT40 cells (CCE) or by the addition of 3 µg/ml anti-IgM in the presence of La3+ and Ca2+ to ThG-pretreated (B-SOC) WT DT40 cells. Maximal increases in fluorescence ratios following the addition of Ca2+ to 1 µM ThG-treated cells (CCE), or the fluorescence ratios 10 minutes after addition of anti-IgM to ThG-pretreated cells (B-SOC) in the presence of La3+ and Ca2+, are shown. Black, YFP-negative cells; blue, YFP-positive cells in samples transfected only with YFP; gray, YFP-positive cells in siOrai1-transfected samples; red, YFP-positive cells in siOrai1 and siOrai2 transfected samples. The total number of cells examined is shown above each column. **P<0.01.

 

Figure 6
View larger version (56K):
[in this window]
[in a new window]

 
Fig. 6. Dynamic behavior of YFP-Stim1 in DT40 cells. (A-C) Stim1-KO cells were transfected with the YFP-Stim1 expression vector. YFP-Stim1-expressing Stim1-KO cells were incubated in nominally Ca2+-free medium for 5 minutes (A) and stimulated with 3 µg/ml anti-IgM in Ca2+-free medium for 10 minutes (B), followed by addition of ThG and incubation for 5 minutes (C). YFP signals of Stim1 near the plasma membrane were monitored by TIRF microscopy. Panels a-f are TIRF images at the beginning (a) and 5 minutes after (b) incubation in nominally Ca2+-free medium, 5 minutes (c) and 10 minutes (d) after the addition of anti-IgM stimulation and 3 minutes (e) and 5 minutes (f) after the addition of ThG. Small TIRF images (a1, a2, c1, c2 and e1) were obtained at 5 second intervals in the areas indicated in panels a, c and e, respectively. Images in a1 and a2 were obtained approximately 3 minutes after incubation in Ca2+-free medium. Images c1 and c2 were obtained approximately 8 minutes after stimulation with anti-IgM. Image e1 was obtained approximately 1.5 minutes after the addition of ThG. The movement of YFP-Stim1 from the white to blue arrowheads is shown on each image. (D) Time-dependent changes in TIRF fluorescence intensity in YFP-Stim1-expressing cells. The trace shown is the mean ± s.e.m. of percentage change in fluorescent intensity, where values at each time point (1 second intervals) were normalized by the average TIRF fluorescence intensity measured for 5 minutes before the addition of anti-IgM and the intensity at 10 minutes after the addition of ThG as the minimum and maximum, respectively. The results are the mean ± s.e.m. of four cells from independent experiments. The horizontal bars indicate the presence of anti-IgM and ThG. The arrows indicate the times of medium exchange.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2009